Skip to main content
MDTMedtronic plc.Buy Wait6.2·$85.50-2.33%
MDT · Concentration risk · 10-K extracted

Medtronic (MDT) concentration risks

Updated

The most significant concentration Medtronic discloses is sole suppliers for certain components, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Medtronic’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 1 disclosed concentration

HIGH1
MEDIUM0
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partySupplier

sole suppliers for certain components

10-K Item 1A: 'certain components, raw materials and services needed to manufacture our products are obtained from sole suppliers'
SEC 10-K · filed Jun 2025
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-07-19

Medtronic discloses a single notable concentration exposure in its source claims: certain components, raw materials, and services needed to manufacture its products are obtained from sole suppliers, a high-share dependency. This is a classic dependency risk rather than a structural one — it reflects reliance on specific, often qualified or hard-to-replace supply relationships rather than any customer, geographic, or macro factor. For a global medical device manufacturer with an enormous and diverse product portfolio, sole-sourcing at the component level is a common industry practice driven by regulatory qualification requirements and specialized manufacturing processes, but it does mean that a disruption at any one of these sole suppliers — whether from a natural disaster, a quality failure, or a business interruption — could constrain production of the specific products that depend on that input until an alternate source is qualified. Because this is the only disclosed concentration in the source claims, there is no broader mosaic of exposures to weigh here; the entire concentration picture rests on how well diversified Medtronic's sole-supplier relationships are across its many product lines, a detail not quantified in the disclosure itself.

For the engine’s reasoning on MDT’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Devices

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
AORTArtivion, Inc.4408
AVNSAvanos Medical, Inc.2013
ATECAlphatec Holdings, Inc.1102
ABTAbbott Laboratories1001
MDTMedtronic plc.1001
AHCOAdaptHealth Corp.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks MDT Concentration risk